Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics
- PMID: 8839661
- DOI: 10.1007/s002280050128
Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics
Abstract
Methods: Twenty-two patients receiving (R)-methadone maintenance treatment were switched to a double dose of (R,S)-methadone: blood samples were collected before and after the change, and the concentrations of the enantiomers were measured. In the second period, during racemic methadone treatment, important interindividual variability in the stereoselective disposition of the enantiomers of methadone was measured, with (R)/(S) ratios ranging from 0.63 to 2.40. This point should be taken into account particularly with respect to therapeutic drug monitoring of racemic methadone.
Results: A significant decrease P < 0.005 in the mean serum concentration/dose ratios of the active (R)-enantiomer before and after the change was measured (mean 3.97 and 3.33).
Conclusion: Although of small amplitude (16%), this decrease confirms previously described adaptive changes in methadone pharmacokinetics during racemic methadone maintenance treatment and may necessitate, in some patients, a dose adjustment.
Similar articles
-
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.Br J Clin Pharmacol. 2000 Nov;50(5):427-40. doi: 10.1046/j.1365-2125.2000.00272.x. Br J Clin Pharmacol. 2000. PMID: 11069437 Free PMC article.
-
Stereoselective pharmacokinetics of methadone in chronic pain patients.Ther Drug Monit. 1996 Jun;18(3):221-7. doi: 10.1097/00007691-199606000-00001. Ther Drug Monit. 1996. PMID: 8738759 Clinical Trial.
-
Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?Clin Ther. 2017 Sep;39(9):1840-1848. doi: 10.1016/j.clinthera.2017.07.044. Epub 2017 Aug 18. Clin Ther. 2017. PMID: 28827023 Clinical Trial.
-
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003. Clin Pharmacokinet. 2002. PMID: 12405865 Review.
-
When "enough" is not enough: new perspectives on optimal methadone maintenance dose.Mt Sinai J Med. 2000 Oct-Nov;67(5-6):404-11. Mt Sinai J Med. 2000. PMID: 11064491 Review.
Cited by
-
Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.Clin Pharmacokinet. 2016 Dec;55(12):1521-1533. doi: 10.1007/s40262-016-0415-2. Clin Pharmacokinet. 2016. PMID: 27286724 Clinical Trial.
-
Genomic and Personalized Medicine Approaches for Substance Use Disorders (SUDs) Looking at Genome-Wide Association Studies.Biomedicines. 2021 Nov 30;9(12):1799. doi: 10.3390/biomedicines9121799. Biomedicines. 2021. PMID: 34944615 Free PMC article. Review.
-
The Impact of Opioids on Cardiac Electrophysiology.Curr Cardiol Rev. 2016;12(1):27-36. doi: 10.2174/1573403x1201160126122405. Curr Cardiol Rev. 2016. PMID: 26818485 Free PMC article. Review.
-
[Requirements of a regional medical service for drug addicted patients].Wien Med Wochenschr. 2006 Feb;156(3-4):102-10. doi: 10.1007/s10354-005-0256-3. Wien Med Wochenschr. 2006. PMID: 16699941 German.
-
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.Br J Clin Pharmacol. 2000 Nov;50(5):427-40. doi: 10.1046/j.1365-2125.2000.00272.x. Br J Clin Pharmacol. 2000. PMID: 11069437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical